Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2026
- #531
- Final score
- 49.16
- Years on list
- 7
↘ Down 43 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 43 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 303 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 123 since 2025
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2026
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | VRTX | WST | HALO |
|---|---|---|---|
| Climate Change | 61.1 | 47.4 | 39.4 |
| Employee Relations | 53.4 | 42.9 | 55.6 |
| Environment | 40.6 | 50.5 | 65.3 |
| Stakeholders & Society | 41.1 | 70.2 | 29.0 |
| Human Rights | 46.3 | 38.7 | 42.0 |
| Governance | 40.4 | 45.4 | 52.1 |
| Performance Rating | 57.4 | 55.3 | 60.5 |